Charles River Laboratories Quick Ratio 2010-2024 | CRL

Historical quick ratio values for Charles River Laboratories (CRL) over the last 10 years.
Charles River Laboratories Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2024-09-30 $1.16B $1.01B 1.15
2024-06-30 $1.15B $0.95B 1.21
2024-03-31 $1.31B $0.96B 1.37
2023-12-31 $1.23B $1.06B 1.16
2023-09-30 $1.15B $0.99B 1.16
2023-06-30 $1.22B $1.01B 1.21
2023-03-31 $1.19B $0.98B 1.21
2022-12-31 $1.18B $1.09B 1.08
2022-09-30 $1.15B $1.01B 1.14
2022-06-30 $1.14B $1.05B 1.08
2022-03-31 $1.11B $0.99B 1.12
2021-12-31 $1.08B $1.03B 1.04
2021-09-30 $1.20B $0.98B 1.22
2021-06-30 $1.07B $0.93B 1.16
2021-03-31 $1.23B $0.80B 1.53
2020-12-31 $1.02B $0.84B 1.21
2020-09-30 $0.96B $0.79B 1.22
2020-06-30 $1.07B $0.73B 1.47
2020-03-31 $1.05B $0.69B 1.51
2019-12-31 $0.86B $0.71B 1.21
2019-09-30 $0.82B $0.68B 1.20
2019-06-30 $0.88B $0.64B 1.38
2019-03-31 $0.74B $0.53B 1.39
2018-12-31 $0.77B $0.56B 1.38
2018-09-30 $0.71B $0.54B 1.32
2018-06-30 $0.77B $0.52B 1.48
2018-03-31 $0.72B $0.41B 1.78
2017-12-31 $0.71B $0.46B 1.54
2017-09-30 $0.68B $0.42B 1.62
2017-06-30 $0.63B $0.42B 1.49
2017-03-31 $0.60B $0.38B 1.57
2016-12-31 $0.56B $0.43B 1.31
2016-09-30 $0.56B $0.41B 1.35
2016-06-30 $0.60B $0.41B 1.46
2016-03-31 $0.54B $0.31B 1.74
2015-12-31 $0.47B $0.31B 1.49
2015-09-30 $0.48B $0.31B 1.53
2015-06-30 $0.54B $0.28B 1.95
2015-03-31 $0.53B $0.27B 1.95
2014-12-31 $0.49B $0.30B 1.66
2014-09-30 $0.51B $0.28B 1.81
2014-06-30 $0.50B $0.27B 1.84
2014-03-31 $0.50B $0.24B 2.09
2013-12-31 $0.46B $0.25B 1.88
2013-09-30 $0.46B $0.24B 1.96
2013-06-30 $0.43B $0.23B 1.91
2013-03-31 $0.41B $0.33B 1.23
2012-12-31 $0.40B $0.34B 1.16
2012-09-30 $0.36B $0.33B 1.12
2012-06-30 $0.36B $0.33B 1.10
2012-03-31 $0.35B $0.22B 1.55
2011-12-31 $0.33B $0.22B 1.54
2011-09-30 $0.36B $0.22B 1.62
2011-06-30 $0.45B $0.28B 1.62
2011-03-31 $0.46B $0.31B 1.50
2010-12-31 $0.45B $0.26B 1.74
2010-09-30 $0.43B $0.24B 1.80
2010-06-30 $0.51B $0.25B 2.08
2010-03-31 $0.52B $0.25B 2.09
2009-12-31 $0.49B $0.25B 1.97
2009-09-30 $0.47B $0.25B 1.83
2009-06-30 $0.47B $0.27B 1.76
2009-03-31 $0.48B $0.28B 1.73
Sector Industry Market Cap Revenue
Medical Medical Services $8.502B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $151.685B 28.04
Elevance Health (ELV) United States $90.559B 11.84
Cencora (COR) United States $47.572B 17.32
Natera (NTRA) United States $23.122B 0.00
DiDi Global (DIDIY) China $22.844B 0.00
ICON (ICLR) Ireland $16.164B 14.40
Avantor (AVTR) United States $14.769B 22.14
Revvity (RVTY) United States $14.502B 24.32
BioMerieux (BMXMF) France $14.256B 0.00
Viatris (VTRS) United States $13.010B 4.01
Solventum (SOLV) United States $12.919B 0.00
CochLear (CHEOY) Australia $12.848B 0.00
Medpace Holdings (MEDP) United States $11.220B 31.61
Doximity (DOCS) United States $10.877B 56.56
EUROFINS SCIENT (ERFSF) Luxembourg $10.037B 0.00
HealthEquity (HQY) United States $9.712B 48.73
Sonic Healthcare (SKHHY) Australia $8.513B 0.00
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $5.661B 26.33
BrightSpring Health Services (BTSG) United States $3.913B 83.22
Sotera Health (SHC) United States $3.909B 20.91
Organon (OGN) United States $3.835B 3.87
Surgery Partners (SGRY) United States $3.260B 37.17
Concentras Parent (CON) United States $2.958B 0.00
Alignment Healthcare (ALHC) United States $2.885B 0.00
PACS (PACS) United States $2.161B 0.00
Ardent Health Partners (ARDT) United States $2.121B 0.00
Teladoc Health (TDOC) United States $2.061B 0.00
Progyny (PGNY) United States $1.859B 37.64
GoodRx Holdings (GDRX) United States $1.837B 48.20
Premier (PINC) United States $1.821B 11.08
GeneDx Holdings (WGS) United States $1.708B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.351B 0.00
CareDx (CDNA) United States $1.217B 0.00
Pediatrix Medical (MD) United States $1.177B 11.51
Embecta (EMBC) United States $1.031B 7.06
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Establishment Labs Holdings (ESTA) $0.848B 0.00
Auna S.A (AUNA) Luxembourg $0.602B 0.00
SBC Medicals (SBC) United States $0.533B 0.00
DocGo (DCGO) United States $0.501B 18.89
Sonida Senior Living (SNDA) United States $0.464B 0.00
InnovAge Holding (INNV) United States $0.435B 0.00
Enhabit (EHAB) United States $0.414B 35.83
QDM (QDMI) Hong Kong, SAR China $0.382B 10.00
MultiPlan (MPLN) United States $0.352B 0.00
Nutex Health (NUTX) United States $0.323B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.317B 0.00
LifeMD (LFMD) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.201B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Sera Prognostics (SERA) United States $0.159B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.104B 17.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
Oncology Institute (TOI) United States $0.067B 0.00
ModivCare (MODV) United States $0.062B 3.35
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Co-Diagnostics (CODX) United States $0.022B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00